South Carolina settles with Pfizer for $45 million for off label marketing of drug

The TortsProf Blog is reporting that South Carolina has settled with pharmaceutical company Pfizer for $45 million for Pfizer's off-label marketing of the anti-psychotic drug, Zyprexa. Interestingly, South Carolina did not participate in the collective suit by 32 states based on the same allegation. If South Carolina has joined that suit, it would have received around $4.5 million. Instead, it brought its own lawsuit. The Post and Courier has more.